Ocugen, Inc. (OCGN) stock
OCGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.76−0.02 (-2.11%)
Close on Nov 17, 2026Market cap $256.61MP/E –Yield –
Ocugen operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Ocugen's operating cash flow for the twelve months ending Jun 30, 2026 was -$60.87M. For fiscal 2025 it was -$56.96M. The highest annual figure on record is -$11.63M in fiscal 2018.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$56.96M | – |
| FY2024 | Dec 31, 2024 | -$42.14M | – |
| FY2023 | Dec 31, 2023 | -$62.05M | – |
| FY2022 | Dec 31, 2022 | -$60.08M | – |
| FY2021 | Dec 31, 2021 | -$47.94M | – |
| FY2020 | Dec 31, 2020 | -$14.71M | – |
| FY2019 | Dec 31, 2019 | -$16.89M | – |
| FY2018 | Dec 31, 2018 | -$11.63M | – |
| FY2017 | Dec 31, 2017 | -$23.02M | – |
| FY2016 | Dec 31, 2016 | -$25.74M | – |
| FY2015 | Dec 31, 2015 | -$30.03M | – |
| FY2014 | Dec 31, 2014 | -$17.94M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$12.20M | – |
| Q1 FY2026 | Mar 31, 2026 | -$21.79M | – |
| Q4 FY2025 | Dec 31, 2025 | -$13.96M | – |
| Q3 FY2025 | Sep 30, 2025 | -$12.92M | – |
| Q2 FY2025 | Jun 30, 2025 | -$10.73M | – |
| Q1 FY2025 | Mar 31, 2025 | -$19.36M | – |
| Q4 FY2024 | Dec 31, 2024 | -$10.36M | – |
| Q3 FY2024 | Sep 30, 2024 | -$11.27M | – |
| Q2 FY2024 | Jun 30, 2024 | -$9.91M | – |
| Q1 FY2024 | Mar 31, 2024 | -$10.60M | – |
| Q4 FY2023 | Dec 31, 2023 | -$11.30M | – |
| Q3 FY2023 | Sep 30, 2023 | -$13.71M | – |
| Q2 FY2023 | Jun 30, 2023 | -$18.81M | – |
| Q1 FY2023 | Mar 31, 2023 | -$18.24M | – |
| Q4 FY2022 | Dec 31, 2022 | -$16.91M | – |
| Q3 FY2022 | Sep 30, 2022 | -$14.30M | – |
| Q2 FY2022 | Jun 30, 2022 | -$13.80M | – |
| Q1 FY2022 | Mar 31, 2022 | -$15.07M | – |
| Q4 FY2021 | Dec 31, 2021 | -$12.80M | – |
| Q3 FY2021 | Sep 30, 2021 | -$8.05M | – |
| Q2 FY2021 | Jun 30, 2021 | -$21.80M | – |
| Q1 FY2021 | Mar 31, 2021 | -$5.28M | – |
| Q4 FY2020 | Dec 31, 2020 | -$4.28M | – |
| Q3 FY2020 | Sep 30, 2020 | -$2.65M | – |
| Q2 FY2020 | Jun 30, 2020 | -$3.09M | – |
| Q1 FY2020 | Mar 31, 2020 | -$4.69M | – |
| Q4 FY2019 | Dec 31, 2019 | -$8.74M | – |
| Q3 FY2019 | Sep 30, 2019 | -$2.12M | – |
| Q2 FY2019 | Jun 30, 2019 | -$3.36M | – |
| Q1 FY2019 | Mar 31, 2019 | -$2.67M | -181.2% |
| Q4 FY2018 | Dec 31, 2018 | -$2.79M | – |
| Q3 FY2018 | Sep 30, 2018 | -$6.92M | – |
| Q2 FY2018 | Jun 30, 2018 | -$5.21M | – |
| Q1 FY2018 | Mar 31, 2018 | $3.29M | – |
| Q4 FY2017 | Dec 31, 2017 | -$4.32M | – |
| Q3 FY2017 | Sep 30, 2017 | -$5.73M | – |
| Q2 FY2017 | Jun 30, 2017 | -$5.63M | – |
| Q1 FY2017 | Mar 31, 2017 | -$7.35M | – |
| Q4 FY2016 | Dec 31, 2016 | -$5.89M | – |
| Q3 FY2016 | Sep 30, 2016 | -$5.46M | – |
See a number that looks wrong?